Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
07/2009
07/15/2009CN101481363A Method for preparing repaglinide
07/15/2009CN101481362A Method for preparing hexamethylene imine
07/15/2009CN100513399C Process for preparing N-benzyl piperazine
07/14/2009USRE40851 3,3-diphenylpropylamines, their use and preparation
07/14/2009US7560589 Cycloalkylidene compounds as modulators of estrogen receptor
07/14/2009US7560582 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants
07/14/2009US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR)
07/14/2009CA2532818C (thio) carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists
07/09/2009WO2009082884A1 Methods for preparing n-substituted morpholine compounds
07/09/2009WO2009082845A1 N-{1-[3-(2-ethoxy-5-(4-ethylpiperazinyl)benzenesulfonyl)-4,5-dihydro-5-oxo-1,2,4-triazin-6-yl]ethyl}butyramide, the preparation method and use thereof
07/09/2009WO2008154642A3 Antibacterial agents
07/09/2009US20090176984 Isotopically Enriched N-Substituted Piperazine Acetic Acids And Methods For The Preparation Thereof
07/09/2009US20090175809 Merocyanine derivatives for cosmetic use
07/09/2009US20090175793 Treatment of male sexual dysfunction
07/08/2009EP2077109A1 Amide compound, salt thereof, and biofilm remover using them
07/08/2009EP2076494A1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds
07/08/2009EP2076491A1 New benzamide derivatives as bradykinin antagonists
07/08/2009EP2076125A2 Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use
07/08/2009CN101479238A Amine derivative having npyy5 receptor antagonist activity
07/08/2009CN100509790C Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
07/08/2009CN100509774C Acylsulfonamides as inhibitors of steroid sulfatase
07/08/2009CN100509771C Method for the production of sulphamic acid halogenides
07/07/2009CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
07/02/2009WO2009081892A1 Novel catechol derivative, pharmaceutical composition containing the same, and use of those
07/02/2009WO2009080515A1 Method for the production of an amine
07/02/2009WO2009080514A1 Method for the production of an amine
07/02/2009WO2009080510A1 Method for the production of an amine
07/02/2009WO2009080509A1 Method for producing an amine
07/02/2009WO2009080508A1 Method for producing an amine
07/02/2009WO2009080507A1 Method for producing an amine
07/02/2009WO2009080506A1 Method for producing an amine
07/02/2009WO2009079941A1 A method for preparing buflomedil
07/02/2009WO2009012201A3 Process for the preparation of trifluoroalkyl-phenyl and heterocyclic sulfonamides
07/02/2009US20090170941 Pharmaceutical Compounds
07/02/2009US20090170881 New inhibitors of histone deacetylase
07/02/2009US20090170870 Amidine-containing compounds useful as muscarinic receptor antagonists
07/02/2009US20090170841 Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders
07/02/2009US20090170836 New inhibitors of histone deacetylase
07/02/2009US20090170824 Diarylsulfones as 5-HT2A Antagonists
07/01/2009EP2074105A1 Cyclopropyl-piperazine compounds as calcium channel blockers
07/01/2009EP2074083A1 New sulfonamide derivatives as bradykinin antagonists
07/01/2009EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers
07/01/2009EP1511721B1 Guanidino phenylalanin compounds used as urokinase inhibitors
07/01/2009EP1406858B1 Substituted 4-aminocyclohexanols
07/01/2009CN101472907A Cinnamoyl-piperazine derivatives and their use as PAR-1 antagonists
07/01/2009CN101472906A 1- [2- (2, 4-dimethylphenylsulfanyl) -phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
07/01/2009CN100506809C Chiral benzhydryl piperazine derivatives and its preparation method
07/01/2009CN100506776C NK1 antagonists
06/2009
06/30/2009US7553976 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
06/30/2009US7553971 Aryl aniline β2 adrenergic receptor agonists
06/30/2009US7553969 Substituted phenethylamine derivatives
06/30/2009US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma
06/30/2009US7553872 Compounds and compositions for delivering active agents
06/30/2009US7553864 TACE inhibitors; rheumatoid arthritis, osteoarthritis, periodontitis, gingivitis, corneal ulceration, neovascular glaucoma, inflammatory bowel disease, multiple sclerosis and psoriasis
06/30/2009US7553861 Type-2 diabetes
06/30/2009US7553841 Amino cyclobutylamide modulators of chemokine receptor activity
06/30/2009US7553837 Phenylazole compounds production process and antioxidants
06/30/2009US7553831 Beta-secretase inhibitors; inhibiting cleavage of amyloid precursor protein (APP); hydroxy-functional disubstituted amines such as 6-(([[(2S,3S)-4-(3,5-difluorophenyl)-3-((3-[(dipropylamino)carbonyl]benzoyl)amino)-2-hydroxybutyl](ethyl)amino]carbonyl)amino)hexanoic acid
06/30/2009US7553819 glycerol cyclic pyruvate derivates; inhibit the binding of an immobilized D-proline derivative to serum amyloid P componen; amyloidosis; Alzheimers disease; maturity onset diabetes mellitus
06/25/2009WO2009079593A1 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor
06/25/2009WO2009079490A1 Process and intermediates for the synthesis of heterocyclic substituted piperazines with cxcr3 antagonist activity
06/25/2009WO2009079392A1 Amidine-containing compounds useful as muscarinic receptor antagonists
06/25/2009WO2009079225A1 Cyclopropyl amine derivatives
06/25/2009WO2009078627A2 Method for preparing (r)-(-)-1-[(4-chlorophenyl)phenylmethyl]piperazine
06/25/2009WO2009078394A1 4-hydroxyphenylalkylamine derivative
06/25/2009WO2009077527A1 Anthelmintic agents and their use
06/25/2009WO2009077391A1 Azomethine direct dyes or reduced precursors of azomethine direct dyes obtained from 2-alkylresorcinols, and hair dyeing process using these dyes or precursors
06/25/2009WO2009061744A3 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
06/25/2009US20090163697 Multicomponent coupling and glycopeptide synthesis with cyclic thioanhydrides
06/25/2009US20090163547 Indene derivatives, their preparation and use as medicaments
06/25/2009US20090163496 Antibacterial agents
06/25/2009US20090163482 Tetralines antagonists of the h-3 receptor
06/25/2009CA2709407A1 Anthelmintic agents and their use
06/25/2009CA2709081A1 Cyclopropyl amine derivatives
06/24/2009EP2072485A1 Stabilizers for the stabilization of unsaturated hydrocarbon-based precursor
06/24/2009EP1558567B1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds
06/24/2009CN101466694A Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
06/24/2009CN101466693A Piperidine derivatives as human papilloma virus inhibitors
06/24/2009CN101463019A Amidine compounds containing aryl, arylmethyl and piperazinyl
06/24/2009CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase
06/24/2009CN100503560C Substituted cyclohexane derivatives
06/24/2009CN100502861C Medicament inhibiting sodium/calcium exchange system
06/23/2009US7550499 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
06/23/2009US7550491 Ionic liquids having [N(CF3)2]− anions
06/23/2009US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
06/23/2009US7550485 Conditions ameliorated by monoamine reuptake such as hot flashes, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders; e.g. 1-[2-(1,4'-bipiperidin-1'-yl)-1-(3-chlorophenyl)ethyl]cyclohexanol dihydrochloride
06/23/2009US7550469 Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
06/23/2009US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases
06/23/2009US7550457 Therapy of vascular system diseases
06/23/2009US7550456 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder
06/23/2009CA2504735C Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
06/23/2009CA2420694C Guanidinobenzamides as mc4-r agonists
06/18/2009WO2009076399A2 Aminotetralin compounds as mu opioid receptor antagonists
06/18/2009WO2009027249A3 Method for producing amines from sugar alcohols
06/18/2009US20090156824 Hydroamination of Alkenes
06/18/2009US20090156806 Process for the Preparation of Oxazolidinone Derivatives
06/18/2009US20090156805 Cycloalkane Carboxamide Derivatives and Production Process of Same
06/18/2009US20090156594 Heterocyclic kinase modulators
06/18/2009US20090156589 1,2-di(cyclic group)substituted benzene derivative
06/17/2009EP2069294A1 Soluble epoxide hydrolase inhibitors
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 341